Saw Palmetto
Saw palmetto is studied mainly for prostate and urinary symptoms in men. Evidence quality varies.
Overview
What is saw palmetto?
Saw palmetto (Serenoa repens) is a tree or small palm. The fruit of the tree is used for its effects on testosterone.
Saw palmetto blocks the enzyme that converts testosterone into dihydrotestosterone (DHT), which is linked to hair loss. Saw palmetto may support hair regrowth and is also used to relieve benign prostatic hyperplasia (BPH) and urinary symptoms, though evidence is mixed. More well-designed studies are needed to confirm these benefits.
Dosage
A typical dose of saw palmetto is 160–320 mg per day.
Effect graph
Effect heatmap
SupplementDEX Database
7 conditions for , and rated at least stars. All purchase bands. No minimum star filter.
Database Snapshot
Most saw palmetto research is concentrated in a handful of conditions.
- Benign prostatic hyperplasia (BPH) accounts for 43 of 67 studies (64%).
- Hair loss accounts for 8 of 67 studies (12%).
- Prostatitis accounts for 5 of 67 studies (7%).
- Sparse coverage remains for Male sexual dysfunction, Prostate cancer.
Safety
Oral saw palmetto is likely safe at typical doses. Oral saw palmetto is possibly safe at a dose of up to 640 mg per day for 30 days.
Frequently Asked Questions
References
Sources65 references
SupplementDEX uses only high-quality sources to determine supplement effectiveness.
1.SupplementDEX Database: Transurethral resection of the prostate (TURP) — Serenoa repens (Permixon®) reduces intra- and postoperative complications of surgical treatments of benign prostatic hyperplasia2010
In 120 BPH patients before prostate surgery, 2 months of Permixon 320 mg/day shortened operative time, reduced bleeding and transfusion needs, and shortened catheterization versus no pretreatment.
2.SupplementDEX Database: Transurethral resection of the prostate (TURP) — Effects of short-term dutasteride and Serenoa repens on perioperative bleeding and microvessel density in patients undergoing transurethral resection of the prostate2009
In 75 men before TURP, 5 weeks of dutasteride reduced intraoperative bleeding and prostatic microvessel density versus control, while Serenoa repens 160 mg/day did not.
3.SupplementDEX Database: Transurethral resection of the prostate (TURP) — Efficacy of pretreatment with Serenoa repens on bleeding associated with transurethral resection of prostate2004
In 88 BPH patients before TURP, at least 8 weeks of Permixon 320 mg/day reduced perioperative bleeding (124 vs 287 mL) and shortened catheterization versus no pretreatment.
SupplementDEX Database · Hair loss
8 references4.SupplementDEX Database: Hair loss — A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair2025
A 6-month RCT in men aged 21–61 with thinning hair found a standardized botanical nutraceutical improved blinded investigator hair growth and quality ratings versus placebo.
5.SupplementDEX Database: Hair loss — Oral Supplementation with l-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study2025
In 80 adults with chronic telogen effluvium or androgenetic alopecia over 6 months, an oral l-cystine, Serenoa repens, cucurbita, and pygeum supplement increased hair density versus placebo.
6.SupplementDEX Database: Hair loss — Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects - A 16-Week Randomized, Placebo-Controlled Study2023
A 16-week RCT in 80 adults with mild-to-moderate androgenetic alopecia found oral or topical standardized saw palmetto oil (VISPO) reduced hair fall by up to 29% versus placebo.
7.SupplementDEX Database: Hair loss — A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia2023
In 54 men with androgenetic alopecia, four sessions of topical Procapil plus PRP and redensyl-saw palmetto-biotin plus PRP both improved hair grading, with no significant between-group difference.
8.SupplementDEX Database: Hair loss — Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia2020
A systematic review of 7 alopecia studies found topical and oral saw palmetto (100–320 mg) associated with improved hair quality and density, though high-quality RCT data were limited.
9.SupplementDEX Database: Hair loss — Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study2012
In 100 men with mild-to-moderate androgenetic alopecia over 24 months, finasteride 1 mg/day improved hair growth in 68% versus 38% with Serenoa repens 320 mg/day.
10.SupplementDEX Database: Hair loss — A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia2002
In men with androgenetic alopecia, a double-blind trial of Serenoa repens liposterolic extract plus beta-sitosterol showed a highly positive hair-regrowth response versus placebo.
11.Effect of gelatin-cystine and serenoa repens extract on free radicals level and hair growth. See external sourceExternal source
12.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Serenoa repens for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement: An Updated Cochrane Review2024
An updated Cochrane review of 27 RCTs in 4656 men found Serenoa repens alone provided little to no benefit for lower urinary tract symptoms due to benign prostatic enlargement vs placebo.
13.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study2022
A matched real-world study in 783 men with moderate-to-severe LUTS/BPH found hexanic Serenoa repens extract 320 mg/day for 6 months improved IPSS more than watchful waiting (3.8 vs 2.2 points).
14.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study2022
In 136 matched men with moderate-to-severe LUTS/BPH, 6 months of tamsulosin plus hexanic Serenoa repens matched tamsulosin plus a 5-ARI for symptom relief but caused fewer adverse events (10.3% vs 26.5%).
15.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials2021
A network meta-analysis of 22 RCTs in 8564 men found Serenoa repens did not produce clinically meaningful improvements in LUTS or peak urinary flow vs placebo.
16.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients2021
A matched comparison in 737 men with moderate-to-severe LUTS/BPH found hexanic Serenoa repens 320 mg/day and tamsulosin 0.4 mg/day for 6 months improved IPSS similarly, with fewer adverse events on HESr (2.1% vs 14.7%).
17.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis2020
A meta-analysis of 4 studies in 1080 BPH patients after at least 6 months found Serenoa repens matched tamsulosin for IPSS, quality of life, and flow rate, though tamsulosin reduced prostate volume more.
18.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study2020
A 6-month observational subset of 709 men with moderate-to-severe LUTS/BPH found tamsulosin plus hexanic Serenoa repens improved IPSS more than either monotherapy (7.2 vs 5.7 vs 5.4 points).
19.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency2020
A 12-week double-blind RCT in 99 men aged 40–65 with BPH found β-sitosterol-enriched saw palmetto oil 500 mg/day improved IPSS, flow rates, PSA, and free testosterone vs placebo and conventional oil.
20.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies2018
A meta-analysis of 27 studies in 5800 LUTS/BPH patients found Permixon hexanic extract 320 mg/day reduced nocturia and improved peak flow vs placebo and matched tamsulosin and short-term 5-ARIs for symptoms.
21.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study)2018
A 6-month non-inferiority RCT in 427 men aged 50–80 found Serenoa repens plus selenium and lycopene was not inferior to tadalafil 5 mg for IPSS and peak flow, with fewer adverse events.
22.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia2017
In 70 men with symptomatic BPH followed 12 months, 40 treated with Serenoa repens alcohol extract had improved urine flow, prostate volume, and IPSS vs 30 untreated controls.
23.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials2016
A meta-analysis of 12 Permixon RCTs found hexanic Serenoa repens reduced nocturnal voids and improved peak flow vs placebo, matched tamsulosin and finasteride for symptoms, and had less sexual dysfunction.
24.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study2015
A 12-month open RCT in 103 Korean BPH men found tamsulosin plus Serenoa repens 320 mg/day improved storage symptoms more than tamsulosin alone at 6 and 12 months, with similar voiding and flow outcomes.
25.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial)2014
In 225 men with LUTS/BPH, Serenoa repens plus lycopene and selenium combined with tamsulosin significantly improved IPSS, Qmax, and PVR at 6 and 12 months versus monotherapies.
26.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment2014
In 36 BPH patients, 3 months of Difaprost (Serenoa, quercetin, beta-sitosterol) before surgery reduced post-void residual volume and showed less prostatic edema versus no pretreatment.
27.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial2013
An open 8-week pilot in 82 elderly men with BPH found Prostasan saw palmetto 320 mg/day reduced IPSS from 14.4 to 6.9 and improved sexual function scores versus baseline.
28.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?2013
In 265 men with LUTS/BPH followed about 6 months, tamsulosin plus Serenoa repens did not differ significantly from tamsulosin or Serenoa repens alone on symptom or flow outcomes.
29.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy2013
In 57 men with BPH, 3 months of ProstateEZE Max (containing lycopene) significantly reduced IPSS by 36% and daytime urinary frequency versus placebo.
30.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review2012
An updated Cochrane review of 17 RCTs (2008 men) found Serenoa repens monotherapy did not significantly improve lower urinary tract symptoms versus placebo, including at escalating doses.
31.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project2012
A multicenter observational study of 298 Italian men with BPH on 320–640 mg/day Serenoa repens reported symptomatic improvement, though this uncontrolled design limits causal inference.
32.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Serenoa repens for benign prostatic hyperplasia2012
A Cochrane systematic review found Serenoa repens extracts had uncertain effects on LUTS in BPH due to heterogeneous products and limited high-quality trial evidence.
33.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial2011
In 369 North American men with LUTS, escalating saw palmetto to 960 mg/day for 72 weeks did not improve AUASI scores, flow rate, or other urinary outcomes versus placebo.
34.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China2008
A 12-week double-blind RCT in 92 Chinese men aged 49–75 with LUTS found Prostataplex saw palmetto improved maximum flow rate (14.1 vs 11.7 mL/s) versus placebo.
35.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin2006
A 60-week RCT in 140 men with BPH-related LUTS found PRO 160/120 (sabal plus urtica) non-inferior to tamsulosin 0.4 mg/day, with median IPSS falling 9 points in both groups.
36.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Saw palmetto for benign prostatic hyperplasia2006
In 225 men over 49 with moderate-to-severe BPH treated 1 year, saw palmetto 320 mg/day twice daily did not improve AUASI, peak flow, prostate volume, or quality of life versus placebo.
37.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial2005
In 257 elderly men with BPH, 24 weeks of PRO 160/120 (sabal plus urtica) reduced IPSS more than placebo; open-label extension continued benefit through 48 weeks.
38.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract2004
An analysis of 14 commercial Serenoa repens brands found wide variation in free fatty acid and ester content, suggesting product differences may affect clinical efficacy and safety.
39.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial2003
In 100 men with BPH over 12 weeks, 320 mg/day Serenoa repens extract did not significantly improve IPSS, peak flow, or erectile function versus placebo.
40.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study2002
In 542 men with symptomatic BPH over 12 months, Permixon 320 mg/day matched tamsulosin 0.4 mg/day for IPSS and flow improvements without reducing prostate volume or PSA.
42.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms2001
In 85 men with LUTS over 6 months, saw palmetto modestly reduced IPSS versus placebo (16.7 to 12.3 vs 15.8 to 13.6; P=0.038) but did not improve peak flow or sexual function.
43.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH)2001
A 3-month RCT in 127 men with BPH found a cernitin, saw palmetto, beta-sitosterol, and vitamin E combination reduced nocturia and daytime frequency versus placebo.
44.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia2000
A meta-analysis of 13 Permixon trials (2859 patients) found Permixon increased peak flow by 2.20 mL/s and reduced nocturia by 0.50 episodes versus placebo.
45.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia2000
In 44 men with symptomatic BPH over 6 months, a saw palmetto herbal blend modestly improved clinical parameters and reduced transition-zone epithelium on MRI versus placebo.
46.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome2000
In 431 BPH patients, combined sabal and urtica (PRO 160/120) matched finasteride for flow improvement over 24 weeks, with similar benefits regardless of baseline prostate volume.
47.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Efficacy and tolerability of the lipidosterolic extract of Serenoa repens (Permixon) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens1999
In 100 BPH outpatients over 3 months, Permixon 320 mg once or twice daily similarly improved IPSS, flow rates, and residual urine versus baseline, with good tolerability.
48.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review1998
A systematic review of 18 BPH RCTs (2939 men) found saw palmetto modestly improved urinary symptoms versus placebo, though trial quality and product heterogeneity limited certainty.
49.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients1996
In 1098 men with moderate BPH over 6 months, Permixon 320 mg/day matched finasteride 5 mg/day for symptom relief but did not reduce prostate volume or PSA like finasteride.
50.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Long-term drug treatment of benign prostatic hyperplasia - results of a prospective 3-year multicenter study using Sabal extract IDS 891996
A 3-year prospective study of 435 men with BPH on Sabal extract IDS 89 reported sustained symptom improvement, higher peak flow, and lower surgery rates than untreated comparators.
51.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia1995
In 63 BPH patients over 3 weeks, alfuzosin 2.5 mg three times daily reduced symptoms more than Serenoa repens 160 mg twice daily on Boyarsky and flow measures.
52.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — [Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens]1992
In 45 BPH patients over 12 weeks, prazosin controlled irritative symptoms slightly better than Serenoa repens, though both treatments improved flow and symptoms.
53.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — The value of permixon in benign prostatic hypertrophy1986
A double-blind trial in BPH patients found Permixon 160 mg twice daily and placebo both improved flow and symptoms, with no significant between-group difference.
54.SupplementDEX Database: Benign prostatic hyperplasia (BPH) — A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia1984
A double-blind trial evaluated Serenoa repens extract for benign prostatic hyperplasia; published abstract details on dose, duration, and outcomes were not available.
41.What is the benefit of combining tamsulosin with serenoa repens versus tamsulosin alone on storage/filling and voiding Lower Urinary Tract Symptoms (LUTS)?. See external sourceExternal source
55.SupplementDEX Database: Lower urinary tract symptoms — Beneficial effects of saw palmetto (Serenoa repens) fruit extract on the urinary symptoms of healthy Japanese adults with possible lower urinary tract symptoms: A randomized, double-blind, placebo-controlled study2024
In 66 healthy Japanese adults aged 50+ without BPH over 12 weeks, saw palmetto extract 320 mg/day reduced daytime urinary bother from overactive bladder symptoms versus placebo.
56.SupplementDEX Database: Lower urinary tract symptoms — Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study2022
In a 12-week RCT in Japanese women with LUTS, saw palmetto fruit extract reduced daytime frequency and nocturia scores versus placebo, especially in those with urgency symptoms.
57.SupplementDEX Database: Lower urinary tract symptoms — The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial2012
In 369 men from the CAMUS trial, escalating saw palmetto to 960 mg/day for 72 weeks did not significantly change serum PSA versus placebo at 24, 48, or 72 weeks.
58.SupplementDEX Database: Male sexual dysfunction — Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials2021
A meta-analysis of 20 studies found Serenoa repens did not significantly worsen male sexual function versus placebo or tamsulosin in BPH trials.
SupplementDEX Database · Prostate cancer
2 references59.SupplementDEX Database: Prostate cancer — Saw Palmetto for Symptom Management During Radiation Therapy for Prostate Cancer2016
In prostate cancer patients undergoing radiation, saw palmetto up to 960 mg/day was safe but did not significantly improve LUTS versus placebo in this small exploratory RCT.
60.SupplementDEX Database: Prostate cancer — Saw palmetto supplement use and prostate cancer risk2006
In 35,171 men aged 50–76 followed 2.3 years, saw palmetto use was not associated with reduced prostate cancer risk (HR 0.95; 95% CI 0.74–1.23).
SupplementDEX Database · Prostatitis
5 references61.SupplementDEX Database: Prostatitis — Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)2014
In 210 men with chronic bacterial prostatitis, prulifloxacin plus Serenoa repens, lactobacillus, and arbutin for 30 days improved symptoms versus antibiotic alone in this randomized trial.
62.SupplementDEX Database: Prostatitis — Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study2013
In 56 chronic prostatitis patients, adding Serenoa repens for 8 weeks to prulifloxacin improved pain and urinary symptoms more than antibiotic alone in this observational study.
63.SupplementDEX Database: Prostatitis — [Approaches to raising efficacy of treatment of patients with chronic prostatitis associated with intracellular infections]2010
In 30 men with chronic infectious prostatitis, indigal plus (including Serenoa repens) with sparfloxacin cleared intracellular pathogens more effectively than sparfloxacin alone over 90 days.
64.SupplementDEX Database: Prostatitis — Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study2009
In 143 chronic bacterial prostatitis patients, prulifloxacin plus ProstaMEV and FlogMEV cleared symptoms in 89.6% at 1 month versus 27% with antibiotic alone.
65.SupplementDEX Database: Prostatitis — [Efficiency and safety of prostamol-Uno in patients with chronic abacterial prostatitis]2006
In 54 men with chronic abacterial prostatitis, prostamol Uno 320 mg improved NIH-CPSI, IPSS, and peak flow versus watchful waiting in this open-label study.